Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy (Q62977698)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Fred Romijn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

F H de Man

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A van der Laarse

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A H Smelt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J A Gevers Leuven

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Sturk

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 October 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

407-414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Large platelets continue to circulate in an activated state after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Smoking, Platelets and Thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Platelet function in hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

In Vivo Platelet Activation in Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Hypertriglyceridaemia and hypercoagulability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Factor VII, cholesterol, and triglycerides. The CARDIA Study. Coronary Artery Risk Development in Young Adults Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Increased in vitro platelet aggregation in hypertriglyceridemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Flow cytometric analysis of platelet activation markers CD62P and CD63 in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Membrane microviscosity and human platelet function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Platelet membrane fluidity in type IIA, type IIB and type IV hyperlipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Superoxide anions enhance platelet adhesion and aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Role of hydroxyl radicals in the activation of human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Platelet activation by oxidatively modified low density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

The in vitro effects of chylomicron remnant and very low density lipoprotein remnant on platelet aggregation in blood obtained from healthy persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Altered Metabolism (In Vivo and In Vitro) of Plasma Lipoproteins after Selective Chemical Modification of Lysine Residues of the Apoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900485-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(99)00485-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10998469%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference